Early Bird Ends Wednesday September 30!

Lock In Your Spot for 2027 With the AIxBio Founders, Biopharma Leaders, and Investors Building the Future of Biology

Name: SynBioBeta 2026 | AI and Biology
Start: 2026-05-04T09:00:00
End: 2026-05-07T18:00:00
Location: San Jose

SynBioBeta 2027. May 3-6, San Jose, California

Get Your Super Early Bird Pass

Previous Speakers Include

Jennifer Doudna

UC Berkeley

Nobel Laureate in Chemistry

Jennifer Doudna

UC Berkeley

Nobel Laureate in Chemistry

Sam Altman

OpenAI

CEO

Sam Altman

OpenAI

CEO

Steve Wozniak

Fusion-io

Chief Scientist

Steve Wozniak

Fusion-io

Chief Scientist

Vinod Khosla

Khosla Ventures

Founder & Partner

Vinod Khosla

Khosla Ventures

Founder & Partner

Frances Arnold

Caltech

Nobel Laureate

Frances Arnold

Caltech

Nobel Laureate

Eric Schmidt

Schmidt Science

Chair & CEO

Eric Schmidt

Schmidt Science

Chair & CEO

Kate Rubins

NASA

Astronaut

Kate Rubins

NASA

Astronaut

Craig Venter

JCVI

Craig Venter

JCVI

Christina Smolke

Antheia

CEO & Co-Founder

Christina Smolke

Antheia

CEO & Co-Founder

George Church

Harvard Medical School

Professor

George Church

Harvard Medical School

Professor

Thomas Bostick

Ginkgo Bioworks

Chairman

Thomas Bostick

Ginkgo Bioworks

Chairman

Ro Khanna

U.S. Congress

Ro Khanna

U.S. Congress

Peter Diamandis

XPRIZE

Founder

Peter Diamandis

XPRIZE

Founder

Drew Endy

Stanford University

Hoover Inst Fellow

Drew Endy

Stanford University

Hoover Inst Fellow

Kevin Scott

Microsoft

CTO

Kevin Scott

Microsoft

CTO

Cathie Wood

Ark Invest

Founder & CEO

Cathie Wood

Ark Invest

Founder & CEO

Hermann Hauser

Amadeus Capital

Founder

Hermann Hauser

Amadeus Capital

Founder

Emily Leproust

Twist Bioscience

CEO

Emily Leproust

Twist Bioscience

CEO

Oliver Morton

The Economist

Senior Editor

Oliver Morton

The Economist

Senior Editor

Daphne Koller

Insitro

Founder & CEO

Daphne Koller

Insitro

Founder & CEO

Jay Keasling

UC Berkeley

Professor

Jay Keasling

UC Berkeley

Professor

Thomas Knight

University of Florida

Dept. Chair & Professor

Thomas Knight

University of Florida

Dept. Chair & Professor

Eben Bayer

Ecovative

CEO

Eben Bayer

Ecovative

CEO

Esther Dyson

BAMF Health

Executive Founder

Esther Dyson

BAMF Health

Executive Founder

Jim Collins

Author

Jim Collins

Author

Lora Kolodny

CNBC

Tech Reporter

Lora Kolodny

CNBC

Tech Reporter

D.A. Wallach

Time BioVentures

General Partner & Co-Founder

D.A. Wallach

Time BioVentures

General Partner & Co-Founder

Gavin Newsom

Governor of California

Gavin Newsom

Governor of California

Pardis Sabeti

Harvard

Professor

Pardis Sabeti

Harvard

Professor

George Whitesides

CA-27

Congressman

George Whitesides

CA-27

Congressman

Eleni Kounalakis

CA Lieutenant Governor

Eleni Kounalakis

CA Lieutenant Governor

Gaurab Chakrabarti

Solugen

Co-Founder & CEO

Gaurab Chakrabarti

Solugen

Co-Founder & CEO

Jeanne Loring

Scripps, Aspen Neuro

Professor

Jeanne Loring

Scripps, Aspen Neuro

Professor

Alison Snyder

Axios

Managing Editor

Alison Snyder

Axios

Managing Editor

Jason Kelly

Ginkgo Bioworks

Founder & CEO

Jason Kelly

Ginkgo Bioworks

Founder & CEO

Ron Weiss

MIT

Professor

Ron Weiss

MIT

Professor

Steve Jurvetson

Future Ventures

Co-Founder

Steve Jurvetson

Future Ventures

Co-Founder

Jennifer Holmgren

LanzaTech

CEO

Jennifer Holmgren

LanzaTech

CEO

Tim O'Reilly

Reilly Media

CEO

Tim O'Reilly

Reilly Media

CEO

Sean O'Sullivan

SOSV

Founder

Sean O'Sullivan

SOSV

Founder

Tim Kopra

Nanoracks

CEO

Tim Kopra

Nanoracks

CEO

Alexandre Zanghellini

Arzeda

Co-founder & CEO

Alexandre Zanghellini

Arzeda

Co-founder & CEO

Previous sponsors & exhibitors

“SynBioBeta is a who’s who of AI and biology.
This is where the future is being built, so don't miss it”

Eric Schmidt

Former CEO

"For every single fund at Boom Capital, one of our best companies has come directly from SynBioBeta. I met Mammoth Bio at SynBioBeta, and I met Nabla Bio at SynBioBeta."

Celestine Schnugg

Founder

"Nabla was accelerated into existence because of SynBioBeta. I met Seth Bannon from 50 Years, Cee Cee Schnugg from Boom Capital, and others from Y Combinator there, and those same people seeded Nabla. The vibe, leverage, and energy at SynBioBeta are unreal."

Surge Biswas

Founder

"Our Series A came together because of a little bit of SynBioBeta magic. I’ve been attending for a decade and it’s been inspiring to watch the field evolve from a lot of hopes and dreams to real products and applications."

Jacob Glanville

Founder & CEO

"I met Algen at SynBioBeta and later invested in the company. It’s exactly the kind of connection that makes the community so valuable."

Bill Tai

Co-founder

"At SynBioBeta I met the team at Biomatter, an AI-driven enzyme design company. The environment made it easy to start a real conversation. That conversation turned into a collaboration to improve one of our enzymes. We're now exploring entirely new performance possibilities together."

Luis Cascao-Pereira

Head of Digital Biology

"Every time I attend SynBioBeta, I walk away with something transformative – a new investor, a fantastic hire, or an idea that changes how we work. It’s a community unlike any other."

Ola Wlodek

CEO

Super Early Bird ends midnight Wednesday, September 30. Lock in your rate now.

Early Stage Startup

/ Non-Profit

1,245

USD

Regular Rate

$1495

Get Your Ticket

Full Conference Pass

1,745

USD

Regular Rate

$2,995

Get Your Ticket

Full Conference Pass + Hotel

2,795

USD

Regular Rate

$3,995

Get Your Ticket

All passes are fully refundable.

Students: Join our next gen leaders program by clicking here.

Secure Your Spot in the Exhibit Hall

Do Business with the CEOs, Executives, and Investors
Driving the Global Bioeconomy

Talk to Our Sales Team

Early Bird Ends Wednesday September 30!

Lock In Your Spot for 2027 With the AIxBio Founders, Biopharma Leaders, and Investors Building the Future of Biology

Lock In Your Spot for 2027 With the AIxBio Founders, Biopharma Leaders, and Investors Building the Future of Biology

SynBioBeta 2027. May 3-6, San Jose, California

SynBioBeta 2027. May 3-6, San Jose, California

SynBioBeta 2027. May 3-6, San Jose, California

Previous Speakers Include

Previous sponsors & exhibitors

“SynBioBeta is a who’s who of AI and biology.
This is where the future is being built, so don't miss it”

“SynBioBeta is a who’s who of AI and biology.
This is where the future is being built, so don't miss it”

"For every single fund at Boom Capital, one of our best companies has come directly from SynBioBeta. I met Mammoth Bio at SynBioBeta, and I met Nabla Bio at SynBioBeta."

"Nabla was accelerated into existence because of SynBioBeta. I met Seth Bannon from 50 Years, Cee Cee Schnugg from Boom Capital, and others from Y Combinator there, and those same people seeded Nabla. The vibe, leverage, and energy at SynBioBeta are unreal."

"Nabla was accelerated into existence because of SynBioBeta. I met Seth Bannon from 50 Years, Cee Cee Schnugg from Boom Capital, and others from Y Combinator there, and those same people seeded Nabla. The vibe, leverage, and energy at SynBioBeta are unreal."

"Our Series A came together because of a little bit of SynBioBeta magic. I’ve been attending for a decade and it’s been inspiring to watch the field evolve from a lot of hopes and dreams to real products and applications."

"Our Series A came together because of a little bit of SynBioBeta magic. I’ve been attending for a decade and it’s been inspiring to watch the field evolve from a lot of hopes and dreams to real products and applications."

"I met Algen at SynBioBeta and later invested in the company. It’s exactly the kind of connection that makes the community so valuable."

"I met Algen at SynBioBeta and later invested in the company. It’s exactly the kind of connection that makes the community so valuable."

"At SynBioBeta I met the team at Biomatter, an AI-driven enzyme design company. The environment made it easy to start a real conversation. That conversation turned into a collaboration to improve one of our enzymes. We're now exploring entirely new performance possibilities together."

"At SynBioBeta I met the team at Biomatter, an AI-driven enzyme design company. The environment made it easy to start a real conversation. That conversation turned into a collaboration to improve one of our enzymes. We're now exploring entirely new performance possibilities together."

"Every time I attend SynBioBeta, I walk away with something transformative – a new investor, a fantastic hire, or an idea that changes how we work. It’s a community unlike any other."

"Every time I attend SynBioBeta, I walk away with something transformative – a new investor, a fantastic hire, or an idea that changes how we work. It’s a community unlike any other."

Super Early Bird ends midnight Wednesday, September 30. Lock in your rate now.

USD

USD

USD

Secure Your Spot in the Exhibit Hall

Do Business with the CEOs, Executives, and Investors
Driving the Global Bioeconomy

Subscribe for

2027 Event Updates

Early Bird Ends Wednesday September 30!

Lock In Your Spot for 2027 With the AIxBio Founders, Biopharma Leaders, and Investors Building the Future of Biology

Lock In Your Spot for 2027 With the AIxBio Founders, Biopharma Leaders, and Investors Building the Future of Biology

SynBioBeta 2027. May 3-6, San Jose, California

SynBioBeta 2027. May 3-6, San Jose, California

SynBioBeta 2027. May 3-6, San Jose, California

Previous Speakers Include

Previous sponsors & exhibitors

“SynBioBeta is a who’s who of AI and biology. This is where the future is being built, so don't miss it”

“SynBioBeta is a who’s who of AI and biology. This is where the future is being built, so don't miss it”

"For every single fund at Boom Capital, one of our best companies has come directly from SynBioBeta. I met Mammoth Bio at SynBioBeta, and I met Nabla Bio at SynBioBeta."

"Nabla was accelerated into existence because of SynBioBeta. I met Seth Bannon from 50 Years, Cee Cee Schnugg from Boom Capital, and others from Y Combinator there, and those same people seeded Nabla. The vibe, leverage, and energy at SynBioBeta are unreal."

"Nabla was accelerated into existence because of SynBioBeta. I met Seth Bannon from 50 Years, Cee Cee Schnugg from Boom Capital, and others from Y Combinator there, and those same people seeded Nabla. The vibe, leverage, and energy at SynBioBeta are unreal."

"Our Series A came together because of a little bit of SynBioBeta magic. I’ve been attending for a decade and it’s been inspiring to watch the field evolve from a lot of hopes and dreams to real products and applications."

"Our Series A came together because of a little bit of SynBioBeta magic. I’ve been attending for a decade and it’s been inspiring to watch the field evolve from a lot of hopes and dreams to real products and applications."

"I met Algen at SynBioBeta and later invested in the company. It’s exactly the kind of connection that makes the community so valuable."

"I met Algen at SynBioBeta and later invested in the company. It’s exactly the kind of connection that makes the community so valuable."

"At SynBioBeta I met the team at Biomatter, an AI-driven enzyme design company. The environment made it easy to start a real conversation. That conversation turned into a collaboration to improve one of our enzymes. We're now exploring entirely new performance possibilities together."

"At SynBioBeta I met the team at Biomatter, an AI-driven enzyme design company. The environment made it easy to start a real conversation. That conversation turned into a collaboration to improve one of our enzymes. We're now exploring entirely new performance possibilities together."

"Every time I attend SynBioBeta, I walk away with something transformative – a new investor, a fantastic hire, or an idea that changes how we work. It’s a community unlike any other."

"Every time I attend SynBioBeta, I walk away with something transformative – a new investor, a fantastic hire, or an idea that changes how we work. It’s a community unlike any other."

Super Early Bird ends midnight Wednesday, September 30. Lock in your rate now.

USD

USD

USD

Secure Your Spot in the Exhibit Hall

Do Business with the CEOs, Executives, and InvestorsDriving the Global Bioeconomy

Subscribe for

2027 Event Updates

“SynBioBeta is a who’s who of AI and biology.
This is where the future is being built, so don't miss it”

“SynBioBeta is a who’s who of AI and biology.
This is where the future is being built, so don't miss it”

Do Business with the CEOs, Executives, and Investors
Driving the Global Bioeconomy